Anticoagulation
Conditions
Interventions
Group 1:Warfarin+Compound salvia miltiorrhiza
Sponsors
Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Warfarin users; 2. Aged 18 to 65 years old, male or female; 3. Sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) There are surgery in recent days or surgery within 3 days, brain, spinal cord and eye surgery; (2) There are a blood coagulation dysfunction disease, bleeding tendency; (3) There are activity in patients with peptic ulcer, Vitamin K deficiency in patients with a variety of reasons, tissues and organs injury bleeding patients; (4) Patients with severe liver and kidney disease, patients with cerebral hemorrhage and cerebral aneurysm, patients with infective endocarditis.With seere high blood pressure and blood pressure was not effective controller, poorly controlled diabetes blood sugar; (5) There are pregnancy or lactation women; (6) Allergic constitution; (7) All subjects having used the compound danshen dropping pill within three days; (8) Not appropriate to the participants judged by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| warfarin in plasma;coagulation testing; | — |
Countries
China
Contacts
Public ContactYuhong Huang
Outcome results
None listed